-
Palestinian-American hoists US flag on home besieged by settlers
-
Aussie Rules club suspends five players for drinking, bringing women to hotel
-
Freedom Holding Marks New Türkiye Milestone as Freedom Yatırım Secures Brokerage License
-
Trump pauses 50% tariffs on Canadian goods for three days
-
Humanoid resources: China's robots search for workforce breakthrough
-
Five Premier League stars to watch this season
-
China goes rural with data centres in quest to power AI
-
China's robots open to opportunities in search of commercial breakthrough
-
Trump pauses planned 50% tariffs on Canadian goods for three days
-
Tech leads losses as Asian stocks track Wall St selloff
-
Ikitau, Suaalii named in Australia squad for Argentina Tests
-
US, South Korea cut drills short after Trump criticism
-
'American Doctor' shows brutality of conflict in Gaza
-
Italian scientists bet on octopus to fight crab invasion
-
New Zealand blocks lawsuits against firms over climate harm
-
New 'Insidious' reflects anxiety of being a new parent: director
-
Aussie Rules club suspends five players amid police probe
-
No.1 Sabalenka slams Wang to advance at Cincinnati
-
No.1 Sabalenka slams Wang to power ahead in Cincinnati
-
Turkey rejects Israeli claims after strike on Syria air base
-
Israel blames Turkey after strike on Syria air base
-
Climate change main driver of European ocean warming: study
-
Trump, Carney talk as Canada seeks to hold off new US tariffs
-
Gauff finds a way into the Cincinnati fourth round
-
NASA images reveal crater left by SpaceX rocket's Moon crash
-
ZZ Top drummer Frank Beard dies at age 77
-
UN atomic watchdog says found tons of nuclear material at Syria site
-
Bayern's Musiala reveals 'neurological disorder' after on-field collapse
-
Ecuadoran diplomat enters race to be next UN chief
-
Angelique Kidjo immortalised on Hollywood Walk of Fame
-
US sanctions ICC chief Tomoko Akane of Japan
-
France to expel two Iranian diplomats: foreign minister
-
US moves to open vast tracts of pristine forests to logging
-
Spain's Granada closes iconic Alhambra as new quake hits
-
US sanctions International Criminal Court chief Tomoko Akane of Japan
-
Venus, Stephens, Monfils named among US Open wild cards
-
Meta hooked children and misled public: prosecutors
-
Rodri joins La Liga champions Barcelona from Manchester City
-
France's first women's rights minister Yvette Roudy dies, aged 97
-
Disney, ABC sue US regulator over threat to broadcast licenses
-
French producer Nicolas Altmayer, Dior PR chief Favier die in car crash
-
Trump, Carney hold talks as new US tariffs on Canada loom
-
Bezos consortium bought nearly 40 percent of Liverpool: report
-
Germany opens new drone research centre as security threats mount
-
Trump says no Iran talks planned, claims Hormuz 'new US territory'
-
How only a few tree species drive Amazon forest recovery
-
Canada seeks to avert new US tariffs as deadline looms
-
Ivonne A-Baki enters race to be next UN chief
-
US primaries test Democrat comeback hopes in Trump stronghold
-
Ukraine says Russian strike kills 10 in northeast region
US pharmacy chain CVS to pay $5 bn in opioid settlement
US pharmacy chain CVS Health said Wednesday they had agreed to pay approximately $5 billion over 10 years to "resolve all opioid lawsuits and claims" against them by states and cities.
The opioid crisis, which has caused more than 500,000 deaths over 20 years in the United States, has triggered a flurry of lawsuits against drugmakers, distributors and pharmacies from victims as well as cities, counties and states impacted by the fallout.
"We are pleased to resolve these longstanding claims and putting them behind us is in the best interest of all parties, as well as our customers, colleagues and shareholders," CVS chief policy officer Thomas Moriarty said in a statement.
"We are committed to working with states, municipalities and tribes, and will continue our own important initiatives to help reduce the illegitimate use of prescription opioids," he added.
The agreement in principle covers claims by all governmental entities in the United States, the statement said.
The company, which is set to begin payouts next year, clarified that the settlement is "not an admission of any liability or wrongdoing."
"CVS Health will continue to defend against any litigation that the final agreement does not resolve," the statement said.
CVS chief executive officer Karen Lynch told an earnings call that the company recognizes "the seriousness of the opioid abuse misconduct has had on so many Americans."
"I just would say that we have made significant investments over the years to combat the opioid crisis and continue to do so through our leadership and our behavioral health company," she said when asked about the settlement.
- Multiple lawsuits -
Walgreens and Walmart have also agreed to settlements of at least $4 billion and $3 billion, according to a report by Bloomberg.
The two companies did not immediately confirm the report to AFP.
CVS earlier this year announced an agreement to pay $484 million to the state of Florida to settle opioid claims, with the money set to fund treatments for drug misuse and health effects of the crisis.
The chain, along with Walgreens, Rite Aid and Walmart, agreed last summer to a $26 million settlement with two counties in New York state.
And an Ohio jury last November sided with two of the state's counties that sued Walmart, Walgreens and CVS, determining the three companies acted illegally in filling significant opioid prescriptions, creating an "oversupply" of the drugs and a "public nuisance."
Such payouts from and decisions against retail pharmacies come alongside other large agreements involving drug manufacturers and distributors, which are alleged to have encouraged doctors to over-prescribe medication which they knew was potentially addictive.
Israeli drugmaker Teva in July announced an agreement in principle to pay more than $4 billion to plaintiffs, and in March, Purdue Pharma reached an agreement with several US states to pay up to $6 billion.
For many people, opioid addiction begins with prescribed pain pills, before they increase their consumption and eventually turn to illicit drugs such as heroin and fentanyl, an extremely powerful synthetic opioid.
Opioid victims and their families addressed the Sackler family, owners of Purdue Pharma, directly in a US courtroom in March as part of the company's bankruptcy case.
"We buried Matthew and Kyle because of your family's vicious acts of disregard for human life," Liz Fitzgerald said of the deaths of two of her sons, who died at ages 32 and 25 after years of dealing with opioid addictions.
"Two boys are gone because of your 'safe' medication," Fitzgerald said.
D.Qudsi--SF-PST